Use of composition comprising proteasome inhibitor, nucleoside analog and interferon for producing an agent for treating hepatitis-C infection, and for treating against interferon and nucleoside analog resistant hepatitis-C virus infection

摘要

Use of a composition comprising a proteasome inhibitor, a nucleoside analog and an interferon for producing an agent for treating hepatitis-C infection, is claimed. ACTIVITY : Antiinflammatory; Hepatotropic; Virucide. MECHANISM OF ACTION : Proteasome inhibitor.